Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 3Peripheral Nervous System Diseases 3Ovarian Neoplasms 3Lung Neoplasms 3Carcinoma, Hepatocellular 3Stomatitis 2Stomach Neoplasms 2Pseudomyxoma Peritonei 2Ototoxicity 2Neurofibromatosis 1 2Neoplasms 2Liver Neoplasms 2Hearing Loss 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Weight Loss 1Ulcer 1Tongue Neoplasms 1Tomaculous neuropathy 1Thrombocythemia, Essential 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Renal Insufficiency, Chronic 1Renal Artery Obstruction 1Radiation-Induced Mucositis 1Radiation Pneumonitis 1Pulmonary Embolism 1Primary Myelofibrosis 1Primary Graft Dysfunction 1

Interventions

Rituximab 344Cyclophosphamide 317fludarabine phosphate 142Etoposide 139Peripheral Blood Stem Cell Transplantation 124fludarabine 112Filgrastim 112Mycophenolic Acid 98Melphalan 98Whole-Body Irradiation 90Vincristine 90Busulfan 87Cytarabine 85Doxorubicin 79Cyclosporine 76Tacrolimus 75Radiotherapy 75Prednisone 73Bendamustine Hydrochloride 72Granulocyte Colony-Stimulating Factor 66Methotrexate 65Antilymphocyte Serum 56Carmustine 54Dexamethasone 50Gemcitabine 48Lenalidomide 46Bortezomib 43venetoclax 41ibritumomab tiuxetan 37obinutuzumab 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Non-Hodgkin × Acetylcysteine × Clear all
NCT00196885 2008-06-20

Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training

German Cancer Research Center

Phase 2 Completed
60 enrolled
GastrointestinalLymphoid

Carcinoma, Bronchogenic, Gastrointestinal Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Muscular Atrophy, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡